Edington H, Agarwala S, Kirkwood J M
Division of Plastic and Reconstructive Surgery, Magee Womens Hospital, University of Pittsburgh Medical Center, University of Pittsburgh Cancer Institute, Pennsylvania 15213, USA.
Clin Plast Surg. 2000 Oct;27(4):643-65.
Biologic therapy has evolved as a fourth treatment option for patients with melanoma and other malignancies. Interrelated advances in molecular diagnostics and gene therapy techniques will further accelerate therapeutic advances in this new arena. A variety of biologic therapeutic options available to the patient with high risk melanoma are reviewed.
生物疗法已发展成为黑色素瘤和其他恶性肿瘤患者的第四种治疗选择。分子诊断和基因治疗技术的相关进展将进一步加速这一新领域的治疗进展。本文综述了高危黑色素瘤患者可采用的多种生物治疗选择。